XML 46 R37.htm IDEA: XBRL DOCUMENT v3.23.3
Stockholders’ Deficit (Tables)
9 Months Ended
Sep. 30, 2023
Stockholders' Equity Note [Abstract]  
Schedule of Stock Option and Restricted Stock Activity
Stock option and restricted stock activity for the Plans was as follows for the nine months ended September 30, 2023:

Options outstandingRestricted stock
outstanding
Number of
shares
available for
issuance
under the
Plans
Number of
shares
outstanding
under the
Plans
Weighted-
average
exercise
price
per share
Weighted-
average
remaining
contractual
term
(In years)
Aggregate intrinsic valueNumber of
shares
outstanding
under the
Plans
Weighted-
average
grant date
fair value
per share
Balance at December 31, 2022
97.9 0.4 $11.30 4.5$4.5 34.8 $23.40 
Additional shares authorized17.5 — — — — — — 
Options exercised and restricted stock units and awards released— (0.2)10.59 — — (11.5)22.76 
Options and restricted stock units and awards canceled10.0 — — — — (10.0)22.25 
Shares withheld related to net share settlement of restricted stock units and awards4.1 — — — — — — 
Options and restricted stock units and awards granted(20.4)— — — — 20.4 22.23 
Balance as of September 30, 2023
109.1 0.2 $12.73 4.2$2.2 33.7 $22.89 
Vested at September 30, 2023
0.2 $12.73 4.2$2.2 — $— 
Unvested at September 30, 2023
— $— — $— 33.7 $22.89 
Schedule of Pre-Tax Intrinsic Value of Options Exercised
The following table summarizes information about the pre-tax intrinsic value of options exercised during the three and nine months ended September 30, 2023 and 2022:

Three Months Ended
September 30,
Nine Months Ended
September 30,
2023202220232022
Intrinsic value of options exercised$0.8 $0.6 $3.0 $2.5